India's Transgene Biotek claims early success in oral insulin for rats
This article was originally published in Scrip
Executive Summary
The Indian company, Transgene Biotek, has reported encouraging early results for its oral delivery technology for insulin, though industry experts say it may be premature to flag up the progress made as material.